It was partially contradictory with the study of D. Kempuraj, etc. They found out CD4+T cells and CD19+ B cells increased after the treatment in both benign and malignant brain tumor patients, on the contrary, CD8+T cells decreased (42). The gene discussed is CD8A; the disease is brain cancer.